- Clinical Trials
- EA9161 A Randomized Phase III Study of the Addition of Venetoclax to Ibrutinib and Obinutuzumab Versus Ibrutinib and Obinutuzumab in Untreated Younger Patients with Chronic Lymphocytic Leukemia (CLL)
What You Need To Know: Temporary Visitor Restrictions | COVID-19 Vaccine